Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma

被引:7
|
作者
Herishanu, Yair [1 ,2 ]
Levi, Shai [1 ]
Kamdjou, Talia [2 ]
Bornstein, Yotam [1 ]
Ram, Ron [1 ,2 ]
Benyamini, Noam [1 ]
Varon, David [1 ,3 ]
Avivi, Irit [1 ,2 ]
Perry, Chava [1 ,2 ]
机构
[1] Tel Aviv Sourasky Med Ctr, Dept Hematol, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Hadassah Hebrew Univ Med Ctr, Coagulat Unit, Jerusalem, Israel
关键词
obinutuzumab; AIHA; ITP; CLL; RITUXIMAB; EFFICACY; ADULTS; SAFETY; CLL;
D O I
10.1111/bjh.17105
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E1 / E4
页数:4
相关论文
共 50 条
  • [1] Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia
    Rider, Tom G.
    Grace, Richard J.
    Newman, Joel A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (02) : 326 - 327
  • [2] Chronic lymphocytic leukaemia/small lymphocytic lymphoma treatment with rituximab and high-dose methylprednisolone, revisited
    Mata, Ana Vagos
    Espada, Eduardo
    Alves, Daniela
    Polo, Blanca
    Costa, Maria Joao
    Lopes, Conceicao
    Lacerda, Joao F.
    Raposo, Joao
    CANCER MEDICINE, 2021, 10 (24): : 8768 - 8776
  • [3] Management of patients with previously untreated chronic lymphocytic leukaemia with obinutuzumab and chlorambucil
    Tam, Constantine
    Kuss, Bryone
    Opat, Stephen
    Boulos, Joy
    Marlton, Paula
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 5 - 10
  • [4] Autoimmune Diseases in Haematology - Immune Thrombocytopenia and Autoimmune Haemolytic Anaemia
    Schmalzing, M.
    Faul, C.
    AKTUELLE RHEUMATOLOGIE, 2016, 41 (02) : 145 - 151
  • [5] Auto Immune Haemolytic in Chronic Lymphocytic Leukaemia (CLL)
    Rashid, Uzair
    Rashid, Arsala
    Virk, Somayya
    Rafiq, Humera
    Zia, Rashid
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (01): : 349 - 351
  • [6] Obinutuzumab: A Review of Its Use in Patients with Chronic Lymphocytic Leukaemia
    Hoy, Sheridan M.
    DRUGS, 2015, 75 (03) : 285 - 296
  • [7] OBINUTUZUMAB FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
    Rogers, K. A.
    Jones, J. A.
    DRUGS OF TODAY, 2014, 50 (06) : 407 - 419
  • [8] Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia
    Hill, Brian T.
    Kalaycio, Matt
    ONCOTARGETS AND THERAPY, 2015, 8 : 2391 - 2397
  • [9] Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands
    Blommestein, Hedwig M.
    de Groot, Saskia
    Aarts, Mieke J.
    Vemer, Pepijn
    de Vries, Robin
    van Abeelen, Annet F. M.
    Posthuma, E. F. M. Ward
    Uyl-de Groota, Carin A.
    LEUKEMIA RESEARCH, 2016, 50 : 37 - 45
  • [10] Idelalisib for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma
    Barrientos, Jacqueline C.
    FUTURE ONCOLOGY, 2016, 12 (18) : 2077 - 2094